199 related articles for article (PubMed ID: 30410641)
1. Hydroxysafflor Yellow A Shows Protection against PPAR
Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.
Wang X; Ma Z; Fu Z; Gao S; Yang L; Jin Y; Sun H; Wang C; Fan W; Chen L; Zheng QY; Bi G; Ma CL
ASN Neuro; 2016; 8(2):. PubMed ID: 27067428
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Liu L; Si N; Ma Y; Ge D; Yu X; Fan A; Wang X; Hu J; Wei P; Ma L; Chen Z; Zhang Q; Feng C
Med Sci Monit; 2018 Feb; 24():803-811. PubMed ID: 29417935
[TBL] [Abstract][Full Text] [Related]
5. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors.
Yang Q; Yang ZF; Liu SB; Zhang XN; Hou Y; Li XQ; Wu YM; Wen AD; Zhao MG
Neurochem Res; 2010 Sep; 35(9):1353-60. PubMed ID: 20526740
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption.
Sun L; Yang L; Xu YW; Liang H; Han J; Zhao RJ; Cheng Y
Brain Res; 2012 Sep; 1473():227-35. PubMed ID: 22867942
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
11. Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury.
Sun L; Yang L; Fu Y; Han J; Xu Y; Liang H; Cheng Y
Nitric Oxide; 2013 Nov; 35():144-51. PubMed ID: 24126016
[TBL] [Abstract][Full Text] [Related]
12. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.
Pei JP; Fan LH; Nan K; Li J; Dang XQ; Wang KZ
J Neuroinflammation; 2017 May; 14(1):97. PubMed ID: 28468657
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
Han B; Hu J; Shen J; Gao Y; Lu Y; Wang T
Eur J Pharmacol; 2013 Aug; 714(1-3):83-8. PubMed ID: 23791614
[TBL] [Abstract][Full Text] [Related]
14. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells.
Lv Y; Qian Y; Ou-Yang A; Fu L
Cell Mol Neurobiol; 2016 Nov; 36(8):1241-1256. PubMed ID: 26754542
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity.
Zhao X; Ou Z; Grotta JC; Waxham N; Aronowski J
Brain Res; 2006 Feb; 1073-1074():460-9. PubMed ID: 16442504
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis.
Chen S; Sun M; Zhao X; Yang Z; Liu W; Cao J; Qiao Y; Luo X; Wen A
Mol Med Rep; 2019 Apr; 19(4):3009-3020. PubMed ID: 30816517
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using
Deng L; Wan H; Zhou H; Yu L; He Y
Eur J Pharmacol; 2018 Apr; 825():119-132. PubMed ID: 29438705
[TBL] [Abstract][Full Text] [Related]
19. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
Lin TN; Cheung WM; Wu JS; Chen JJ; Lin H; Chen JJ; Liou JY; Shyue SK; Wu KK
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):481-7. PubMed ID: 16385084
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.
Thouennon E; Cheng Y; Falahatian V; Cawley NX; Loh YP
J Neurochem; 2015 Aug; 134(3):463-70. PubMed ID: 25940785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
